Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, offering promising progress throughout different medical and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA supplies a safer, more responsible choice for therapeutic use, notably